Projecten per jaar
Persoonlijk profiel
Expertise
- Bone marrow and peripheral blood stem cells: biology and therapeutical use
- Stem cell processing and banking
- Tumo-host interactions in blood cancer (multiple myeloma)
Vingerafdruk
- 1 Soortgelijke profielen
Netwerk
-
FWOSB118: Tumor karakterisatie en ziekteopvolging in multipel myeloom door (epi) genetische typering gebruik makend van liquid biopsies
Heestermans, R. & Van Riet, I.
1/11/21 → 31/10/23
Project: Fundamenteel
-
-
ANI52: Cycle for Life 2007 : Circulating endothelial cells in multiple myeloma: characterisation and study of their role as surrogate marker for myeloma-induced angiogenesis.
Vande Broek, I. & Van Riet, I.
27/09/07 → …
Project: Fundamenteel
-
ANI303: Het gebruik van vloeibare biopsieën voor MRD-detectie bij multipel myeloom
15/10/21 → 31/10/22
Project: Fundamenteel
-
HERC44: FWO Hercules MZW: ERA platform: Extensief RNA Analyse platform
Rooman, I., Baeyens, L., Goossens, E., Vanhaecke, T., van Grunsven, L., Bouwens, L., De Bundel, D., Bautmans, I., Massie, A., Van Riet, I., De Bruyne, E., De Kock, J. & Forsyth, R.
1/05/18 → 30/04/22
Project: Fundamenteel
Onderzoeksoutput
-
790 Phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and AS01B in combination with intravenously administered nivolumab
Tijtgat, J., Schwarze, J. K., Vander Mijnsbrugge, A-S., Raeymaeckers, S., Van Riet, I., Geeraerts, X., Stevens, L., Tuyaerts, S. & Neyns, B., 7 nov 2022, In: Journal for immunotherapy of cancer. 10, Suppl 2Onderzoeksoutput: Meeting abstract (Journal)
Open Access -
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)
Schwarze, J. K., Geens, W., Tijtgat, J., Awada, G., Seynaeve, L., Vanbinst, A-M., Everaert, H., Michotte, A., Bruneau, M., Van Riet, I., Tuyaerts, S., Duerinck, J. & Neyns, B., 1 jun 2022, In: Journal of Clinical Oncology. 40, 16, 2033.Onderzoeksoutput: Meeting abstract (Journal)
Open Access -
Genetic profiling of human bone marrow mesenchymal stromal cells after in vitro expansion in clinical grade human platelet lysate
De Becker, A., Heestermans, R., De Brouwer, W., Bockstaele, K., Maes, K. & Van Riet, I., 12 okt 2022, In: Frontiers in Bioengineering and Biotechnology. 10, 1008271.Onderzoeksoutput: Article › peer review
Open Access -
Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial
Schwarze, J. K., Tijtgat, J., Awada, G., Cras, L., Vasaturo, A., Bagnall, C., Forsyth, R., Dufait, I., Tuyaerts, S., Van Riet, I. & Neyns, B., sep 2022, In: Journal for immunotherapy of cancer. 10, 9, blz. 1-13 13 blz., e005141.Onderzoeksoutput: Article › peer review
Open Access2 Citaten (Scopus) -
Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study
Heestermans, R., De Brouwer, W., Maes, K., Vande Broek, I., Vaeyens, F., Olsen, C., Caljon, B., De Becker, A., Bakkus, M. H. C., Schots, R. & Van Riet, I., 7 okt 2022, In: Cancers. 14, 19, 16 blz., 4901.Onderzoeksoutput: Article › peer review
Open Access
Activiteiten
-
Characterization of the evolving mutational landscape in multiple myeloma during disease progression using blood-derived cell free DNA: an explorative study
Robbe Heestermans (Speaker), Wouter De Brouwer (Contributor), Ken Maes (Contributor), Isabelle Vande Broek (Contributor), Freya Vaeyens (Contributor), Catharina Olsen (Contributor), Toon Janssen (Contributor), Ann De Becker (Contributor), Marleen Bakkus (Contributor), Henri Schots (Contributor) & Ivan Van Riet (Contributor)
3 feb 2023Activiteit: Talk or presentation at a conference
-
The best liquid biopsy for myeloma detection by immunoglobulin targeted NGS
Wouter De Brouwer (Speaker), Ivan Van Riet (Contributor), Robbe Heestermans (Contributor), Jona Van der Straeten (Contributor), Isabelle Vande Broek (Contributor), Marleen Bakkus (Contributor) & Henri Schots (Contributor)
4 feb 2022Activiteit: Talk or presentation at a conference
-
Lab Secrets for Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing (NGS): Strategies to Leverage NGS-based minimal residual disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)
Wouter De Brouwer (Invited speaker), Jona Van der Straeten (Contributor), Ivan Van Riet (Contributor) & Marleen Bakkus (Contributor)
24 feb 2022Activiteit: Talk at a public lecture/debate
-
29th General Annual Meeting of the Belgian Hematological Society
Ivan Van Riet (Speaker)
30 jan 2014 → 31 jan 2014Activiteit: Talk or presentation at a workshop/seminar
-
39th Annual Meeting of the European Group for Blood and Marrow Transplantation
Ivan Van Riet (Keynote speaker)
7 apr 2013 → 10 apr 2013Activiteit: Talk or presentation at a conference
Scriptie
-
Exploring the therapeutic potential of targeting mitotic exit in combination with standard of care agents in high grade B cell malignancies.
Auteur: Maes, A., De Bruyne, E., Vanderkerken, K., Pellat-Deceunynck, C., De Keersmaecker, K., De Grève, J., Gutierrez, G. J. & Van Riet, I., 18 nov 2019Begeleider: De Bruyne, E. (Promotor), Vanderkerken, K. (Promotor), Pellat-Deceunynck, C. (Externe persoon) (Jury), De Keersmaecker, K. (Externe persoon) (Jury), De Grève, J. (Jury), Gutierrez Gonzalez, G. (Jury) & Van Riet, I. (Externe persoon) (Jury)
Scriptie/Masterproef: Doctoral Thesis
-
Homing of myeloma cells and its implication for autologous transplantation
Auteur: Van Riet, I., Van Camp, B. & Geerts, A., 1993Begeleider: Van Camp, B. (Promotor) & Geerts, A. (Jury)
Scriptie/Masterproef: Doctoral Thesis